Islandsbanki hf.: Íslandsbanki issues SEK 300 million private placement
Íslandsbanki hf. has today issued a bond under its Global Medium Term Notes (GMTN) programme with the following terms:
Issuer: Íslandsbanki hf.
Issue size: SEK 300,000,000
Maturity date: 5 July 2021
Listing: Irish Stock Exchange
ISIN: Fungible with XS1851338696
Dealer: Danske Bank
Information on Íslandsbanki's USD 2,500,000,000 GMTN and its supplements are available at: www.islandsbanki.is/english/investor-relations/funding/
For further information:
- Investor Relations – Gunnar S. Magnusson, ir@islandsbanki.is and tel: +354 440 4665.
Íslandsbanki press releases
If you wish to receive Íslandsbanki press releases by e-mail please register at: https://www.islandsbanki.is/english/investor-relations/ir-contacts/e-mail-subscription/
About Íslandsbanki
A leader in financial services in Iceland, Íslandsbanki is a universal bank with total assets of ISK 1,036bn and a 25% - 50% market share across all domestic business segments. Building on over 140 years of servicing key industries, Íslandsbanki has developed specific expertise in tourism, seafood and energy related industries. Driven by the vision to be #1 for service, Íslandsbanki’s relationship banking business model is propelled by three business divisions that manage and build relationships with the Bank´s customers. Íslandsbanki has developed a wide range of online services such as the Íslandsbanki, Kreditkort and Kass apps, enabling customers to do their banking whenever and wherever. At the same time, the Bank continues to operate the most efficient branch network in Iceland through its strategically located 14 branches. For the fifth consecutive year, Íslandsbanki led the Icelandic Customer Satisfactory Index for banks in 2017 and was also named Bank of the Year in Iceland by the Banker. Íslandsbanki has a BBB+/A-2 rating from S&P Global Ratings and BBB/F3 from Fitch Ratings and is the only bank in Iceland rated by two international rating agencies. www.islandsbanki.is
Disclaimer
This press release may contain “forward-looking statements,” involving uncertainty and risks that could cause actual results to differ materially from results expressed or implied by the statements. Íslandsbanki hf. undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. It is the investor's responsibility to not place undue reliance on these forward-looking statements which only reflect the date of this press release. Forward-looking statements should not be considered as guarantees or predictions of future events and all forward-looking statements are qualified in their entirety by this cautionary statement.
© 2018 GlobeNewswire, Inc. All Rights Reserved.
Dicerna Pharmaceuticals (Nasdaq: DRNA) and Novo Nordisk (NYSE: NVO) Enter Agreement to Discover and Develop RNAi Therapies for Liver-Related Cardio-Metabolic Diseases
